PMID- 7157463
OWN - NLM
STAT- MEDLINE
DCOM- 19830311
LR  - 20190904
IS  - 0163-4356 (Print)
IS  - 0163-4356 (Linking)
VI  - 4
IP  - 4
DP  - 1982
TI  - A high pressure liquid chromatographic procedure for monitoring 
      1-(2-chloroethyl)-3-(4-trans-methylcyclohexyl)-1-nitrosourea levels in body 
      fluids.
PG  - 389-95
AB  - A reverse phase high pressure liquid chromatographic method has been developed 
      for the analysis of 1-(2-chloroethyl)-3-(4-trans-methylcyclohexyl)-1-nitrosourea 
      (methyl-CCNU) levels present in body fluids. A value obtained for the plasma 
      half-life for a single patient indicates that this may be larger than hitherto 
      expected.
FAU - Caddy, B
AU  - Caddy B
FAU - Idowu, O R
AU  - Idowu OR
FAU - Stuart, J F
AU  - Stuart JF
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Ther Drug Monit
JT  - Therapeutic drug monitoring
JID - 7909660
RN  - 0 (Nitrosourea Compounds)
RN  - 13909-09-6 (Semustine)
SB  - IM
MH  - Body Fluids/analysis
MH  - Chromatography, High Pressure Liquid/methods
MH  - Humans
MH  - Nitrosourea Compounds/*analysis
MH  - Semustine/*analysis/blood/urine
EDAT- 1982/01/01 00:00
MHDA- 1982/01/01 00:01
CRDT- 1982/01/01 00:00
PHST- 1982/01/01 00:00 [pubmed]
PHST- 1982/01/01 00:01 [medline]
PHST- 1982/01/01 00:00 [entrez]
AID - 10.1097/00007691-198212000-00010 [doi]
PST - ppublish
SO  - Ther Drug Monit. 1982;4(4):389-95. doi: 10.1097/00007691-198212000-00010.